Recent evidence has suggested that CD8 T cells with cytotoxic activity play an important role in anti-tumor immunity, and a higher density of CD8+ T cells is associated with a favorable prognosis in a variety of malignant tumors, including CRC (3, 39, 40). This evidence concerns the gene CD8A and colorectal carcinoma.